Study says Zinc-hydroxychloroquine is effective in some COVID-19 patients

Study says Zinc-hydroxychloroquine is effective in some COVID-19 patients

-The NYU Grossman School of Medicine conducted a study that showed some positive news regarding a possible new treatment against COVID-19

- The study involved 900 COVID-19 patients, with half of them given zinc sulfate along with hydroxychloroquine and the antibiotic azithromycin; the other half were given hydroxychloroquine and azithromycin only

- Those in the first group had a 1.5 times greater likelihood of recovering enough to be discharged from the hospital and 44 percent were less likely to die from the virus compared to the second group

- The said research has not yet been peer-reviewed and needs to be further studied by other experts

PAY ATTENTION: Click "See First" under the "Following" tab to see KAMI news on your News Feed

A new study, conducted by the NYU Grossman School of Medicine, showed some positive news regarding a possible new treatment against COVID-19.

According to Agence France-Presse and ABS-CBN News, the study involved 900 COVID-19 patients, with half of them given zinc sulfate along with hydroxychloroquine and the antibiotic azithromycin.

The other half were given hydroxychloroquine and azithromycin only.

Those in the first group had a 1.5 times greater likelihood of recovering enough to be discharged from the hospital and 44 percent were less likely to die from the virus compared to the second group, who were only given a double-drug combination.

The report clarified that the research has not yet been peer-reviewed and needs to be further studied by other experts.

"The next logical step would be to do a prospective study to see if this holds up in people that you give zinc to, and then you watch and compare," Senior investigator and infectious disease specialist Joseph Rahimian told AFP.

PAY ATTENTION: Enjoyed reading our story? Download KAMI's news app on Google Play now and stay up-to-date with major Filipino news!

There have been other good news when it comes to curing COVID-19 in other parts of the world.

Japan finally approved Gilead Sciences Inc's remdesivir as the country’s first officially authorized drug against COVID-19.

In the US, a study that involved 1,000 patients also gave positive news on remdesivir.

NBC News (authored by Erika Edwards) reported that the patients who received remdesivir were discharged from the hospital within 11 days compared to the 15 days of the patients who received a placebo.

Based on a report by The Guardian (authored by Sarah Bosely), 8 percent of the patients who received the drug died of COVID-19 compared to the 11 percent of the placebo group.

Please like and share our amazing Facebook posts to support the KAMI team! Don’t hesitate to comment and share your opinions about our stories either. We love reading about your thoughts and views on different matters!

Our new episode features a unique challenge: you have to guess the gibberish sentences and phrases! Check out all of the exciting videos and celebrity interviews on our KAMI HumanMeter YouTube channel!

Source: Kami.com.ph

Online view pixel